- Report
- April 2025
- 50 Pages
Global
From €2418EUR$2,650USD£2,079GBP
- Report
- April 2025
- 200 Pages
Global
From €4096EUR$4,490USD£3,523GBP
- Report
- October 2024
- 182 Pages
Global
From €3234EUR$3,545USD£2,781GBP
€3594EUR$3,939USD£3,090GBP
- Report
- April 2025
- 50 Pages
Global
From €2418EUR$2,650USD£2,079GBP
Robenidine is an animal pharmaceutical used to treat coccidiosis, a parasitic disease that affects the digestive system of poultry and other livestock. It is a synthetic compound that works by inhibiting the growth of the protozoan parasites that cause the disease. Robenidine is available in both injectable and oral forms, and is used in a variety of animal species, including chickens, turkeys, ducks, geese, and swine. It is also used in the treatment of other gastrointestinal diseases, such as colibacillosis and salmonellosis.
Robenidine is a widely used animal pharmaceutical, and is available from a number of manufacturers. It is typically sold in the form of tablets, capsules, or powder, and is administered orally or by injection. The drug is also available in combination with other drugs, such as antibiotics, to treat more severe cases of coccidiosis.
Some companies in the Robenidine market include Merck Animal Health, Elanco Animal Health, Zoetis, Bayer Animal Health, and Virbac. Show Less Read more